Generalized pustular figurate erythema first report in two COVID-19 patients on hydroxychloroquine

J Eur Acad Dermatol Venereol. 2021 Jan;35(1):e5-e7. doi: 10.1111/jdv.16903. Epub 2020 Sep 17.

Authors

I Abadías-Granado¹, A M Palma-Ruiz¹, P A Cerro¹, A M Morales-Callaghan¹, M C Gómez-Mateo², Y Gilaberte¹, R A Schwartz³

Affiliations

¹ Department of Dermatology, Miguel Servet University Hospital, IIS Aragón, Zaragoza, Spain.
² Department of Pathology, Miguel Servet University Hospital, IIS Aragón, Zaragoza, Spain.
³ Rutgers University New Jersey Medical School, Newark, NJ, USA.

PMID: 32870539
DOI: 10.1111/jdv.16903

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antimalarials / adverse effects*
COVID-19 Drug Treatment*
Drug Eruptions / etiology*
Drug Eruptions / pathology
Erythema / chemically induced*
Erythema / pathology
Female
Humans
Hydroxychloroquine / adverse effects*
Male
Middle Aged
SARS-CoV-2

Substances

Antimalarials
Hydroxychloroquine